The Life Raft Group presented ‘SDH Webinar: Updates & Stories’ on July 13th, 2022. During this virtual event, Dr. John Glod, Clinical Director of the Pediatric Oncology Branch in the Center for Cancer Research at National Cancer Institute, discussed updates from the NIH Pediatric & Wildtype GIST Clinic, which is a part of My Pediatric and Adult Rare Tumor Network (MyPART)and patient advocate Lleyton Schelesky shared his GIST story.
About our Presenters:
John Glod, MD, PhD
Associate Research Physician, National Cancer Institute, Pediatric Oncology Branch
Dr. Glod obtained his M.D. and Ph.D. from the University of Colorado in Denver and trained in pediatrics and pediatric oncology at Cincinnati Children’s Hospital, Johns Hopkins Hospital, and the Pediatric Oncology Branch of the NCI. Following an fellowship in neuro-oncology at the NCI, Dr. Glod served as faculty in the departments of pediatrics and pharmacology at Rutgers Cancer Institute of New Jersey. Dr. Glod joined the Pharmacology and Experimental Therapeutics Section in 2013. His research interests focus on understanding the biology of rare pediatric solid tumors and exploring new therapies for patients with these diseases.
Lleyton Schelesky
Patient Advocate
Lleyton was diagnosed with GIST at age 12. Now a young adult, Lleyton shared his experience with SDH-deficient GIST.
